Triamcinolone: New and old indications

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 7, 2001, Pages 1177-1186

  Doggrell, S A ^a  

^a Doggrell Biomedical Communications   (New Zealand)

Author keywords

Bronchial asthma; Chronic obstructive pulmonary disease; Rheumatoid arthritis; Rhinitis; Triamcinolone

Indexed keywords

ASTEMIZOLE; BECLOMETASONE; CORTICOSTEROID; DEXAMETHASONE; FLUDROCORTISONE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE; LORATADINE; NOSE SPRAY; PLACEBO; TRIAMCINOLONE; TRIAMCINOLONE ACETATE; TRIAMCINOLONE HEXACETONIDE;

AEROSOL; ANTIINFLAMMATORY ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ASCITES; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG TOLERABILITY; DUPUYTREN CONTRACTURE; EMERGENCY; EPISTAXIS; HEADACHE; HUMAN; HYPERTROPHIC SCAR; INFLAMMATORY DISEASE; KELOID; KNEE ARTHROSCOPY; LICHEN SCLEROSUS ET ATROPHICUS; MYOCARDITIS; PHARYNGITIS; POSTOPERATIVE CARE; PSEUDOGOUT; RESPIRATORY TRACT INFLAMMATION; RETINA MACULA DEGENERATION; RHEUMATOID ARTHRITIS; RHINITIS; SHOULDER PAIN; VERNAL CONJUNCTIVITIS;

ADMINISTRATION, INTRANASAL; ADULT; AEROSOLS; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; ASTEMIZOLE; ASTHMA; CHILD; CLINICAL TRIALS; CONJUNCTIVITIS, ALLERGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAMUSCULAR; LORATADINE; LUNG DISEASES, OBSTRUCTIVE; MACULAR DEGENERATION; MOLECULAR STRUCTURE; NASAL MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAMCINOLONE;

EID: 0034937095     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.7.1177     Document Type: Article

References (53)

1. Lung Health Study Research Group: Effect of Inhaled Triamcinolone on the Decline in Pulmonary Function in Chronic Obstructive pulmonary Disease
2. Anti-inflammatory actions of glucocorticoids: Molecular mechanism
3. A pharmacokinetic study to evaluate the absolute bioavailability of triamcinolone acetonide following inhalation administration
4. Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults
5. Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers
6. Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults
7. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis
8. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis
9. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma
10. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic
11. Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis
12. Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis
13. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis
14. Preseasonal, once daily triamcinolone acetonide nasal aerosol for seasonal allergic rhinitis
15. Tri-Nasal triamcinolone acetonide nasal spray 200 and 400 micrograms qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 micrograms qd in patients suffering from seasonal allergic rhinitis during the grass season
16. Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled
17. Long-term safety and efficacy of triamcinolone acetonide aqueous nasal spray for the treatment of perennial allergic rhinitis
18. Placebo-controlled, double-blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis
19. A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone nasal spray in subjects with ragweed-induced allergic rhinitis
20. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisolone, and placebo on adrenocortical function in male patients with allergic rhinitis
21. Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids. French Triamcinolone Acetonide Study
22. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis
23. Comparison of intranasal triamcinolone acetonide with oral loratadine in the treatment of seasonal ragweed-induced allergic rhinitis
24. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: Efficacy and quality of life
25. A comparison of triamcinolone acetonide nasal aerosol spray and fluticasone propionate aqueous solution spray in the treatment of spring allergic rhinitis
26. Dose-ranging study of the clinical efficacy of twice-daily triamcinolone acetonide inhalation aerosol in moderately severe asthma
27. A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma
28. A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma
29. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group
30. A controlled trial of chlorofluorocarbon-free triamcinolone acetonide in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group
31. Long-term safety of a non-chlorofluorocarbon-containing triamcinolone acetonide inhalation aerosol in patients with asthma
32. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma
33. Fluticasone alone or in combination with salmeterol vs. triamcinolone in asthma
34. Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma
35. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics
36. Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: A randomized controlled trial
37. Intramuscular high-dose triamcinolone acetonide in the treatment of severe chronic asthma
38. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
39. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
40. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
41. Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone hexacetonide
42. A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis
43. Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis
44. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration
45. Intra-articular triamcinolone acetonide injection in patients with capsulitis of the shoulder: A comparative study of two dose regimens
46. Effect of triamcinolone acetonide injections on hemiplegic shoulder pain: A randomized clinical trial
47. Cushing's syndrome in postburn children following intralesional triamcinolone injection
48. The injection of nodules of Dupuytren's disease with triamcinolone acetonide
49. Prospective use of intramuscular triamcinolone acetonide in pseudogout
50. Intraarticular triamcinolone acetonide for pain control after arthroscopic knee surgery
51. Intralesional injection of triamcinolone in the treatment of lichen sclerosus
52. A Phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites
53. Intraperitoneal treatment of autoreactive myocarditis with triamcinolon. Successful administration in patients with minimal pericardial effusion